III.14.e.ii—Post-Trial Access
>Control Description
Agreement to participate in the trial under these conditions is a reasonable forgoing of the right of access. Following the conclusion of the trial and analysis of the results, participants should have access to their data if they request it. They should seek it primarily from the physician or other health care provider from whom they received treatment within the clinical trial, or secondarily from the sponsoring organization.
>Cross-Framework Mappings
Ask AI
Configure your API key to use AI features.